ArticleJournal of experimental & clinical cancer research : CR2017

Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment.

Monika Jaruskova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.